Medical Press Release - Page 4 of 12 - Medika Life : Keeping you informed

MAY 30, 2023, AUSTIN, TX – Clinics IV Life, a Texas-based not-for-profit led by a global team of global humanitarians working to counter the climbing...

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained

Medika Life - January 28, 2022

52 physicians from across the U.S. selected for the inaugural cohort of the five-year, $100 million initiative Initiative is part of the BMS Foundation commitment...

Research into gut microbiome-autism link reveals new perspective

Medika Life - November 12, 2021

Latest research on the gut biome and Autism fails to demonstrate a an association between the microbiome and a diagnosis of ASD

Research on Controlling Cellular Outposts of the Immune System

Medika Life - May 12, 2021

New RNA research. The miR-424(322)/503 gene cluster regulates pro- vs anti-inflammatory skin DC subset differentiation by modulating TGF-beta signaling

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

South University Announces New MSPA Program at West Palm Beach Campus

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

Children with no COVID-19 symptoms may shed virus for weeks

EDITORS CHOICE

Clinics IV Life Launches a New Clinic Model to Change the Face of Charitable Maternal Care, Delivery to Impoverished Communities

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained

Research into gut microbiome-autism link reveals new perspective

Research on Controlling Cellular Outposts of the Immune System

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories